In addition, mutations in the immunoreceptor tyrosine-based activation motif (ITAM) of CD79B associated with antigen-activating chronic B-cell receptor (BCR) signaling [18] are also observed in ABC DLBCL samples. Here, CD79B is linked to diffuse large B-cell lymphoma.